Clinical Trial Update: CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow [NA]

View source ↗

Summary

CANARY trial assessing near-infrared spectroscopy for rupture-prone yellow plaques in coronary disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Embolism
• Myocardial Infarction

Snippet

Sponsor: Infraredx | Conditions: Coronary Atherosclerosis, Myocardial Infarction | NA | Status: TERMINATED